Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-β

Journal of Leukocyte Biology

Volumn 79, Issue 5, 2006, Pages 1033-1042

  Cheng, Mei Lien ^a   Chen, Hsin Wei ^a   Tsai, Jy Ping ^a   Lee, Yi Ping ^a   Shih, Yan Chung ^a   Chang, Chung Ming ^a   Ting, Chou Chik ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cytotoxic T lymphocyte; Flow cytometry; Mixed lymphocyte culture

Indexed keywords

RECOMBINANT INTERLEUKIN 2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; EPITOPE; INTERLEUKIN 2; MEMBRANE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL CLONING; CELL CYCLE; CELL GROWTH; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE CULTURE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CELL CLONE; CELL CULTURE; CELL PROLIFERATION; CELLULAR IMMUNITY; COCULTURE; DOWN REGULATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE;

MURINAE;

ANIMALS; ANTIGENS, SURFACE; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CLONAL ANERGY; CLONE CELLS; COCULTURE TECHNIQUES; DOWN-REGULATION; EPITOPES; FEMALE; FLOW CYTOMETRY; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745305790     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0805474     Document Type: Article

References (53)

1. Wahl, S. M. (1994) Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180, 1587-1590.
2. Teng, Y-T., Gorczynski, R. M., Hozumi, N. (1998) The function of TGF-[β]-mediated innocent bystander suppression associated with physiological self-tolerance in vivo. Cell. Immunol. 190, 51-60.
3. Barone, K. S., Tolarova, D. D., Ormsby, I., Doetschman, T., Michael, J. G. (1998) Induction of oral tolerance in TGF-{β}1 null mice. J. Immunol. 161, 154-160.
4. Thorbecke, G. J., Umetsu, D. T., deKruyff, R. H., Hansen, G., Chen, L-Z., Hochwald, G. M. (2000) When engineered to produce latent TGF-[β]1, antigen-specific T cells down regulate Th1 cell-mediated autoimmune and Th2 cell-mediated allergic inflammatory processes. Cytokine Growth Factor Rev. 11, 89-96.
5. Bommireddy, R., Saxena, V., Ormsby, I., Yin, M., Boivin, G. P., Babcock, G. F., Singh, R. R., Doetschman, T. (2003) TGF-{β}1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J. Immunol. 170, 4612-4622.
6. Schiott, A., Sjogren, H. O., Lindvall, M. (1998) The three isoforms of transforming growth factor-β co-stimulate rat T cells and inhibit lymphocyte apoptosis. Scand. J. Immunol. 48, 371-378.
7. Chung, E. J., Choi, S. H., Shim, Y. H., Bang, Y. J., Hur, K. C., Kim, C. W. (2000) Transforming growth factor-β induces apoptosis in activated murine T cells through the activation of caspase 1-like protease. Cell. Immunol. 204, 46-54.
8. Tang, B., Bottinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., Wakefield, L. M. (1998) Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4, 802-807.
9. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., Akhurst, R. J. (1996) TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542.
10. Lee, H. M., Rich, S. (1993) Differential activation of CD8+ T cells by transforming growth factor-β 1. J. Immunol. 151, 668-677.
11. Mule, J. J., Schwarz, S. L., Roberts, A. B., Sporn, M. B., Rosenberg, S. A. (1988) Transforming growth factor-β inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. 26, 95-100.
12. Gray, J. D., Hirokawa, M., Horwitz, D. A. (1994) The role of transforming growth factor β in the generation of suppression: an interaction between CD8+ T and NK cells. J. Exp. Med. 180, 1937-1942.
13. Gray, J. D., Hirokawa, M., Ohtsuka, K., Horwitz, D. A. (1998) Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-{β}: contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 160, 2248-2254.
14. Kondo, S., Isobe, K., Ishiguro, N., Nakashima, I., Miura, T. (1993) Transforming growth factor-β 1 enhances the generation of allospecific cytotoxic T lymphocytes. Immunology 79, 459-464.
15. Tada, T., Ohzeki, S., Utsumi, K., Takiuchi, H., Muramatsu, M., Li, X., Shimizu, J., Fujiwara, H., Hamaoka, T. (1991) Transforming growth factor-β-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J. Immunol. 146, 1077-1082.
16. Swain, S. L., Huston, G., Tonkonogy, S., Weinberg, A. (1991) Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147, 2991-3000.
17. Chang, C. J., Liao, C. H., Wang, F. H., Lin, C. M. (2003) Transforming growth factor-β induces apoptosis in antigen-specific CD4(+) T cells prepared for adoptive immunotherapy. Immunol. Lett. 86, 37-43.
18. Espevik, T., Waage, A., Faxvaag, A., Shalaby, M. R. (1990) Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 β and transforming growth factor-β. Cell. Immunol. 126, 47-56.
19. Fox, F. E., Ford, H. C., Douglas, R., Cherian, S., Nowell, P. C. (1993) Evidence that TGF-β can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell. Immunol. 150, 45-58.
20. Letterio, J. J., Roberts, A. B. (1998) Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137-161.
21. Seder, R. A., Marth, T., Sieve, M. C., Strober, W., Letterio, J. J., Roberts, A. B., Kelsall, B. (1998) Factors involved in the differentiation of TGF-{β}-producing cells from naive CD4+ T cells: IL-4 and IFN-{γ} have opposing effects, while TGF-{β} positively regulates its own production. J. Immunol. 160, 5719-5728.
22. Brown, R. D., Pope, B., Murray, A., Esdale, W., Sze, D. M., Gibson, J., Ho, P. J., Hart, D., Joshua, D. (2001) Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β 1 and interleukin-10. Blood 98, 2992-2998.
23. Kobie, J. J., Wu, R. S., Kurt, R. A., Lou, S., Adelman, M. K., Whitesell, L. J., Ramanathapuram, L. V., Arteaga, C. L., Akporiaye, E. T. (2003) Transforming growth factor {β} inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines. Cancer Res. 63, 1860-1864.
24. Yamagiwa, S., Gray, J. D., Hashimoto, S., Horwitz, D. A. (2001) A role for TGF-β in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J. Immunol. 166, 7282-7289.
25. D'Orazio, T. J., Niederkorn, J. Y. (1998) A novel role for TGF-{β} and IL-10 in the induction of immune privilege. J. Immunol. 160, 2089-2098.
26. Gomes, N. A., Gattass, C. R., Barreto-de-Souza, V., Wilson, M. E., DosReis, G. A. (2000) TGF-{β} mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J. Immunol. 164, 2001-2008.
27. Sullivan, T. J., Letterio, J. J., van Elsas, A., Mamura, M., van Amelsfort, J., Sharpe, S., Metzler, B., Chambers, C. A., Allison, J. P. (2001) Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation. Proc. Natl. Acad. Sci. USA 98, 2587-2592.
28. Pardoux, C., Asselin-Paturel, C., Chehimi, J., Gay, F., Mami-Chouaib, F., Chouaib, S. (1997) Functional interaction between TGF-β and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J. Immunol. 158, 136-143.
29. Gorham, J. D., Guler, M. L., Fenoglio, D., Gubler, U., Murphy, K. M. (1998) Low dose TGF-{β} attenuates IL-12 responsiveness in murine Th cells. J. Immunol. 161, 1664-1670.
30. Pardoux, C., Ma, X., Gobert, S., Pellegrini, S., Mayeux, P., Gay, F., Trinchieri, G., Chouaib, S. (1999) Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-β: relationship with IL-12 signaling. Blood 93, 1448-1455.
31. Bright, J. J., Sriram, S. (1998) TGF-{β} inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161, 1772-1777.
32. Maeda, H., Shiraishi, A. (1996) TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 156, 73-78.
33. Jiang, L. Q., Streilein, J. W. (1991) Immune privilege extended to allogeneic tumor cells in the vitreous cavity. Invest. Ophthalmol. Vis. Sci. 32, 224-228.
34. Fabry, Z., Topham, D., Fee, D., Herlein, J., Carlino, J., Hart, M., Sriram, S. (1995) TGF-β 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J. Immunol. 155, 325-332.
35. Pollanen, P., von Euler, M., Jahnukainen, K., Saari, T., Parvinen, M., Sainio-Pollanen, S., Soder, O. (1993) Role of transforming growth factor β in testicular immunosuppression. J. Reprod. Immunol. 24, 123-137.
36. Chambaz, E. M., Souchelnitskiy, S., Pellerin, S., Defaye, G., Cochet, C., Feige, J. J. (1996) Transforming growth factors-β s: a multifunctional cytokine family. Implication in the regulation of adrenocortical cell endocrine functions. Horm. Res. 45, 222-226.
37. Lucas, P. J., Kim, S-J., Melby, S. J., Gress, R. E. (2000) Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor {β} II receptor. J. Exp. Med. 191, 1187-1196.
38. Gorelik, L., Flavell, R. A. (2000) Abrogation of TGF[β] signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181.
39. Huang, L-R., Chen, F-L., Chen, Y-T., Lin, Y-M., Kung, J. T. (2000) Potent induction of long-term CD8+ T cell memory by short-term IL-4 exposure during T cell receptor stimulation. Proc. Natl. Acad. Sci. USA 97, 3406-3411.
40. Tsai, J-P. T., Chen, H-W., Cheng, M-L., Liu, H-K., Lee, Y-P. L., Hsieh, C. L. H., Luh, K-T., Wu, C-W., Hsu, L-H., Chao, T-Y., Wang, W-H., Chang, C-M. C., Ting, C-C. (2005) Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-β1 and interleukin 6 in the development of in situ tumor immunity. Immunobiology 210, 661-671.
41. Beverly, B., Kang, S. M., Lenardo, M. J., Schwartz, R. H. (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4, 661-671.
42. Shimizu, J., Moriizumi, E. (2003) CD4+CD25- T cells in aged mice are hyporesponsive and exhibit suppressive activity. J. Immunol. 170, 1675-1682.
43. Zheng, S. G., Gray, J. D., Ohtsuka, K., Yamagiwa, S., Horwitz, D. A. (2002) Generation ex vivo of TGF-{β}-producing regulatory T cells from CD4+CD25- precursors. J. Immunol. 169, 4183-4189.
44. Jonuleit, H., Schmitt, E., Kakirman, H., Stassen, M., Knop, J., Enk, A. H. (2002) Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J. Exp. Med. 196, 255-260.
45. Horwitz, D. A., Zheng, S. G., Gray, J. D. (2003) The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+CD25+ and CD8+ regulatory T cell subsets. J. Leukoc. Biol 74, 471-478.
46. Zhang-Hoover, J., Stein-Streilein, J. (2004) Tolerrogenic APC generate CD8+ T regulatory cells that modulate pulmonary interstitial fibrosis. J. Immunol. 172, 178-185.
47. Faunce, D. E., Terajewicz, A., Stein-Streilein, J. (2004) Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalitis. J. Immunol. 172, 1991-1995.
48. Kosiewicz, M. M., Alard, P., Liang, S., Clark, S. L. (2004) Mechanisms of tolerance induced by transforming growth factor-β-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechansim involving Fas ligand. Int. Immunol. 16, 697-706.
49. Myers, L., Croft, M., Kwon, B. S., Mittler, R. S., Vella, A. T. (2005) Peptide-specific CD8 T regulatory cells use IFN-γ to elaborate TGF-β-based suppression. J. Immunol. 174, 7625-7632.
50. Mehal, W. Z., Sheikh, S. Z., Gorelik, L., Flavell, R. A. (2005) TGF-{β} signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions. Int. Immunol. 17, 531-538.
51. McKarns, S. C., Schearts, R. H. (2005) Distinct effects of TGF-β 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. J. Immunol. 174, 2071-2083.
52. Lucas, P. J., McNeil, N., Hilgenfeld, E., Choudhury, B., Kim, S-J., Eckhaus, M. A., Ried, T., Gress, R. E. (2004) Transforming growth factor-{β} pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. Cancer Res. 64, 6524-6529.
53. Ahmadzadeh, M., Rosenberg, S. A. (2005) TGF-{β}1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J. Immunol. 174, 5215-5223.